I think a large part is due to Congress pushing for the Department of Transportation to come up with a plan to deal with driving under the influence of marijuana - as stated in the infrastructure bill just passed. There will be studies, and there will be a push/pull on both sides of the argument whether THC concentration dictates impairment.
This type of controversy always creates a great trading opportunity on both sides of the trade. Over the next 6 months, we can expect to see advancements in Lifeloc's MJ Breathalyzer. Along with that, we will see controversy over whether the breathalyzer will be a valid instrument in determining impairment.
All technical indicators indicate a "Buy" for this stock today.
I'm sure we will see volatility, so be careful setting stop-loss orders. If you are a new investor, use limit orders to buy this stock - you will thank me later.
Have a great evening...!